Karpus Investment Management’s ZyVersa Therapeutics ZVSA Stock Holding History

Karpus Investment Management’s Portfolio ZVSA Stock Details ZVSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-124	Closed	-$432K	–	473
2022 Q3	$432K	Hold	124	–	–	0.02%	416
2022 Q2	$429K	Sell	124 -2	-2%	-$6.95K	0.01%	419
2022 Q1	$435K	Buy	+126	New	+$436K	0.01%	363

Other funds holding ZVSA

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Karpus Investment Management's ZVSA Position: Q4 2022 in Review

Karpus Investment Management sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 124 shares — an estimated $432K sold.

Karpus Investment Management first reported a position in ZVSA in Q1 2022 and held it in 3 quarters. The position peaked at $435K in Q1 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

Karpus Investment Management reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
Karpus Investment Management sold 124 ZyVersa Therapeutics shares in Q4 2022, an estimated $432K.
Karpus Investment Management first reported a position in ZyVersa Therapeutics in Q1 2022 and held it in 3 quarters.
Karpus Investment Management's ZyVersa Therapeutics position peaked at $435K in Q1 2022.
2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on Karpus Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.